SCHEMBL31367967

SCHEMBL31367967

Cc1cc(Br)cc(C)c1-n1nc2nc(N3CCOCC3)[nH]c(=O)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 2/20 0.45
KMT2A Q03164 3/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
PIM1 P11309 1/20 0.39
CDC7 O00311 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
ROCK1 Q13464 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
GAA P10253 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.34
PIK3CB P42338 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31367977 1.00 NLRP3 (0.45) NLRP3KMT2ATSHRMEN1HSD17B10
SCHEMBL31368007 0.90 NLRP3 (0.42) NLRP3KMT2AMEN1SMN1; SMN2PIM1
SCHEMBL31367980 0.90 NLRP3 (0.42) NLRP3KMT2AMEN1SMN1; SMN2PIM1
SCHEMBL31368006 0.90 NLRP3 (0.42) NLRP3KMT2AMEN1SMN1; SMN2PIM1
SCHEMBL31367989 0.87 PIM1 (0.39) NLRP3KMT2ATSHRMEN1HSD17B10
SCHEMBL31367976 0.86 KMT2A (0.41) NLRP3KMT2ATSHRMEN1HSD17B10
SCHEMBL31367971 0.80 KMT2A (0.38) NLRP3KMT2ATSHRMEN1HSD17B10
SCHEMBL29294062 0.80 NLRP3 (0.69) NLRP3KMT2ATSHRMEN1HSD17B10
SCHEMBL31367994 0.79 ADORA1 (0.42) KMT2ATSHRMEN1SMN1; SMN2ADORA3
SCHEMBL31368000 0.77 PDE2A (0.44) KMT2AMEN1SMN1; SMN2ADORA3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092051-A1 NLRP3 MODULATORS AND USE THEREOF Bioentropy Inc. (US) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250092051-A1 NLRP3 MODULATORS AND USE THEREOF NLRP3, NLRP1, NOD1 NLRP3 1/4885KMT2A 1509/4885TSHR 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.